Cancer: Transplant Surgery

Department of Health and Social Care written question – answered on 25th October 2019.

Alert me about debates like this

Photo of Lord Willis of Knaresborough Lord Willis of Knaresborough Liberal Democrat

To ask Her Majesty's Government whether liver and bowel transplantation is currently approved by the National Institute for Health and Care Excellence for cancer patients; and if not, whether there are any clinical trials that have reached Phase 3.

Photo of Baroness Blackwood of North Oxford Baroness Blackwood of North Oxford The Parliamentary Under-Secretary for Health and Social Care

The National Institute for Health and Care Excellence has not produced any guidance relating to combined liver and bowel transplants for cancer patients.

The Department funds research mainly through the National Institute for Health Research (NIHR). The usual practice of the NIHR and other research funders is not to ring-fence funds for expenditure on particular topics. The NIHR welcomes funding applications for research into any aspect of human health, including liver and bowel transplantation.

There has been one relevant clinical trial that reached Phase 3:

Study title: In open, prospective, single arm study investigating efficacy and safety of human hepatitis B immunoglobulin Zutectra in liver transplanted patients - the ZEUS Study.

Date: 22 November 2012 – 10 April 2014

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.